Anti-Diabetic effect of purple corn extract on C57BL/KsJ db/db mice

Nutrition Research and Practice

Volumn 9, Issue 1, 2015, Pages 17-21

  Huang, Bo ^a   Wang, Zhiqiang ^b   Park, Jong Hyuk ^b   Ryu, Ok Hyun ^b   Choi, Moon Ki ^b   Lee, Jae Yong ^b   Kang, Young Hee ^b   Lim, Soon Sung ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b Hallym University   (South Korea)

Author keywords

AMPK; Diabetes; Insulin; Microarray assay; Purple corn

Indexed keywords

MUS; ZEA MAYS;

EID: 84922687798     PISSN: 19761457     EISSN: 20056168     Source Type: Journal    
DOI: 10.4162/nrp.2015.9.1.22     Document Type: Article

References (35)

1. Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care 2003;3:S63-80.
2. Goldfrank L, Lewin N, Flomenbaum N, Howland MA. The pernicious panacea: herbal medicine. Hosp Physician 1982;10:64-9.
3. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989;8:553-64.
4. Jing P, Giusti MM. Characterization of anthocyanin-rich waste from purple corncobs (Zea mays L.) and its application to color milk. J Agric Food Chem 2005;22:8775-81.
5. Fossen T, Slimestad R, Andersen OM. Anthocyanins from maize (Zea mays) and reed canarygrass (Phalaris arundinacea). J Agric Food Chem 2001;5:2318-21.
6. Hagiwara A, Miyashita K, Nakanishi T, Sano M, Tamano S, Kadota T, Koda T, Nakamura M, Imaida K, Ito N, Shirai T. Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett 2001;1:17-25.
7. Tsuda T, Horio F, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside increases ex vivo oxidation resistance of serum in rats. Lipids 1998; 6:583-8.
8. Tsuda T, Shiga K, Ohshima K, Kawakishi S, Osawa T. Inhibition of lipid peroxidation and the active oxygen radical scavenging effect of anthocyanin pigments isolated from Phaseolus vulgaris L. Biochem Pharmacol 1996;7:1033-9.
9. Yoshimoto M, Okuno S, Yoshinaga M, Yamakawa O, Yamaguchi M, Yamada J. Antimutagenicity of sweetpotato (Ipomoea batatas) roots. Biosci Biotechnol Biochem 1999;3:537-41.
10. Li J, Lim SS, Lee JY, Kim JK, Kang SW, Kim JL, Kang YH. Purple corn anthocyanins dampened high-glucose-induced mesangial fibrosis and inflammation: possible renoprotective role in diabetic nephropathy. J Nutr Biochem 2012;4:320-31.
11. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr 2003;7:2125-30.
12. Trinder P. Determination of blood glucose using an oxidaseperoxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969;2:158-61.
13. Goldstein BJ. Insulin resistance as the core defect in type 2 diabetes mellitus. Am J Cardiol 2002;90:3-10.
14. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr 2001;9: 2242-7.
15. Guo H, Guo J, Jiang X, Li Z, Ling W. Cyanidin-3-O-b-glucoside, a typical anthocyanin, exhibits antilipolytic effects in 3T3-L1 adipocytes during hyperglycemia: Involvement of FoxO1-mediated transcription of adipose triglyceride lipase. Food chem Toxicol 2012;9: 3040-7.
16. Zhao X, Corrales M, Zhang C, Hu X, Ma Y, Tauscher B. Composition and thermal stability of anthocyanins from chinese purple corn (Zea mays L.). J Agric Food Chem 2008;22:10761-6.
17. Libby P, Plutzky J. Diabetic macrovascular disease: the glucose paradox? Circulation 2002;22:2760-3.
18. Nishina PM, Naggert JK, Verstuyft J, Paigen B. Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994;5:554-8.
19. Narayanan CR, Joshi DD, Mudjumdar AM, Dhekne VV. Pinitol, a new anti-diabetic compound from the leaves of Bougainvillea spectabilis. Curr Sci 1987;56:139-41.
20. Hong S, Heo J, Kim J, Kwon S, Yeo K, Bakowska-Barczak A, Kolodziejczyk, P, Ryu O, Choi M, Kang Y, Lim S, Suh H, Huh S, Lee J. Antidiabetic and Beta Cell-Protection Activities of Purple Corn Anthocyanins. Biomolecules & Therapeutics 2013;21:284-9.
21. Alberti KG, Zimmet PZ. New diagnostic criteria and classification of diabetes--again? Diabet Med 1998;7:535-6.
22. Scott DK, O'Doherty RM, Stafford JM, Newgard CB, Granner DK. The repression of hormone-activated PEPCK gene expression by glucose is insulin-independent but requires glucose metabolism. J Biol Chem 1998;37:24145-51.
23. Bressler R, Brendel K. The role of carnitine and carnitine acyltransferase in biological acetylations and fatty acid synthesis. J Biol Chem 1966;17:4092-7.
24. Kelly DP, Gordon JI, Alpers R, Strauss AW. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 1989;32:18921-5.
25. Ling B, Aziz C, Alcorn J. Systematic Evaluation of Key L-Carnitine Homeostasis Mechanisms during Postnatal Development in Rat. Nutr Metab (Lond) 2012;1:66.
26. Nemali MR, Usuda N, Reddy MK, Oyasu K, Hashimoto T, Osumi T, Rao MS, Reddy JK. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res 1988;18:5316-24.
27. Tsuchida T, Fukuda S, Aoyama H, Taniuchi N, Ishihara T, Ohashi N, Sato H, Wakimoto K, Shiotani M, Oku A. MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice. Lipids Health Dis 2012; 11:75.
28. Jiang Z, Michal JJ, Chen J, Daniels TF, Kunej T, Garcia MD, Gaskins CT, Busboom JR, Alexander LJ, Wright RW Jr, Macneil MD. Discovery of novel genetic networks associated with 19 economically important traits in beef cattle. Int J Biol Sci 2009;6:528-42.
29. Wu XL, Macneil MD, De S, Xiao QJ, Michal JJ, Gaskins CT, Reeves JJ, Busboom JR, Wright RW Jr, Jiang Z. Evaluation of candidate gene effects for beef backfat via Bayesian model selection. Genetica 2005; 1:103-13.
30. Hardie DG. The AMP-activated protein kinase pathway--new players upstream and downstream. J Cell Sci 2004;23:5479-87.
31. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007;3:328-41.
32. Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci 1999;1:22-5.
33. Rutter GA, Da Silva Xavier G, Leclerc I. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 2003;1:1-16.
34. Velasco G, Geelen MJ, Guzmán M. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism. Arch Biochem Biophys 1997;2:169-75.
35. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Phys 1997;1:1107-12.